Literature DB >> 21620753

Bone metastasis: histological changes and pathophysiological mechanisms in osteolytic or osteosclerotic localizations. A review.

D Chappard1, B Bouvard, M-F Baslé, E Legrand, M Audran.   

Abstract

The development of a bone metastasis involves interactions between the tumor cells, the bone marrow microenvironment and the bone cells themselves. A better understanding of the pathophysiological changes occurring in bone metastasis can be obtained from histopathological examination of invaded specimens. This review focuses on the main molecular mechanisms implied in the localization and growth of malignant cells in the bone marrow. The corresponding histologic developmental stages are illustrated both in osteolytic (or mixed metastasis) or in the osteosclerotic forms by histological analysis, immunohistochemistry and microcomputed tomographic analysis of bone samples. In both cases, the malignant cells find a "fertile soil" in the bone marrow microenvironment. They use the growth factors released by bone cells for the coupling between osteoclasts/osteoblasts to promote their own development. In turn, they elaborate a variety of cytokines that can promote osteoclastogenesis (PTHrP, IL-1, IL-6…) or on the contrary, other growth factors that can boost the osteoblastic activity (ET1, IGFs). A "vicious circle" occurs between the malignant cells and the bone cells leading to the radiological expression of the metastasis.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620753     DOI: 10.1016/j.morpho.2011.02.004

Source DB:  PubMed          Journal:  Morphologie        ISSN: 1286-0115


  12 in total

1.  The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

Authors:  Adam N Wallace; Clifford G Robinson; Jeffrey Meyer; Nam D Tran; Afshin Gangi; Matthew R Callstrom; Samuel T Chao; Brian A Van Tine; Jonathan M Morris; Brian M Bruel; Jeremiah Long; Robert D Timmerman; Jacob M Buchowski; Jack W Jennings
Journal:  Oncologist       Date:  2015-09-09

Review 2.  Evaluation and management of skeletal disease in cancer care.

Authors:  Anuhya Kommalapati; Sri Harsha Tella; Mary Angelynne Esquivel; Ricardo Correa
Journal:  Crit Rev Oncol Hematol       Date:  2017-09-08       Impact factor: 6.312

3.  Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis.

Authors:  Riadh Badraoui; Mariem Boubakri; Maissa Bedbabiss; Hmed Ben-Nasr; Tarek Rebai
Journal:  Tumour Biol       Date:  2013-12-08

4.  Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657).

Authors:  Neelima Vidula; Christina Yau; Jiali Li; Laura J Esserman; Hope S Rugo
Journal:  Breast Cancer Res Treat       Date:  2017-06-02       Impact factor: 4.872

5.  Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.

Authors:  Hongyu Zhao; Weisong Cai; Shuai Li; Zuke Da; Hanxue Sun; Liang Ma; Yaoxin Lin; Debao Zhi
Journal:  Childs Nerv Syst       Date:  2013-04-05       Impact factor: 1.475

Review 6.  Cancer-associated bone disease.

Authors:  R Rizzoli; J-J Body; M-L Brandi; J Cannata-Andia; D Chappard; A El Maghraoui; C C Glüer; D Kendler; N Napoli; A Papaioannou; D D Pierroz; M Rahme; C H Van Poznak; T J de Villiers; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-10-22       Impact factor: 4.507

7.  Sodium Fluoride-18 and Radium-223 Dichloride Uptake Colocalize in Osteoblastic Mouse Xenograft Tumors.

Authors:  Tim E Phelps; Jyoti Roy; Michael V Green; Jurgen Seidel; Kwamena E Baidoo; Stephen Adler; Elijah F Edmondson; Donna Butcher; Jennifer L Matta; Anita T Ton; Karen Wong; Shan Huang; Ling Ren; Amy K LeBlanc; Peter L Choyke; Elaine M Jagoda
Journal:  Cancer Biother Radiopharm       Date:  2021-02-25       Impact factor: 3.099

8.  Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report.

Authors:  Kalevi Kairemo; Nigora Rasulova; Justina Suslaviciute; Tuomo Alanko
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

Review 9.  Cultured circulating tumor cells and their derived xenografts for personalized oncology.

Authors:  Ruoxiang Wang; Gina C Y Chu; Stefan Mrdenovic; Alagappan A Annamalai; Andrew E Hendifar; Nicholas N Nissen; James S Tomlinson; Michael Lewis; Nallasivam Palanisamy; Hsian-Rong Tseng; Edwin M Posadas; Michael R Freeman; Stephen J Pandol; Haiyen E Zhau; Leland W K Chung
Journal:  Asian J Urol       Date:  2016-08-25

Review 10.  Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2.

Authors:  Chia-Hung Yen; Chin-Mu Hsu; Samuel Yien Hsiao; Hui-Hua Hsiao
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.